Perrigo Announces FDA Approval for Generic Version of NASACORT AQ

Perrigo Company today announced that its partner Teva Pharmaceutical Industries Ltd. has received final approval from the U.S. FDA to market Triamcinolone Acetonide Nasal Spray containing a paragraph IV certification.

the details can be read here.